JP2005206602A5 - - Google Patents

Download PDF

Info

Publication number
JP2005206602A5
JP2005206602A5 JP2005013897A JP2005013897A JP2005206602A5 JP 2005206602 A5 JP2005206602 A5 JP 2005206602A5 JP 2005013897 A JP2005013897 A JP 2005013897A JP 2005013897 A JP2005013897 A JP 2005013897A JP 2005206602 A5 JP2005206602 A5 JP 2005206602A5
Authority
JP
Japan
Prior art keywords
antibody
arginine
producing
buffer
purified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2005013897A
Other languages
English (en)
Japanese (ja)
Other versions
JP4826995B2 (ja
JP2005206602A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2005206602A publication Critical patent/JP2005206602A/ja
Publication of JP2005206602A5 publication Critical patent/JP2005206602A5/ja
Application granted granted Critical
Publication of JP4826995B2 publication Critical patent/JP4826995B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2005013897A 2004-01-21 2005-01-21 抗体の変質を防止する精製方法 Expired - Lifetime JP4826995B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US53750304P 2004-01-21 2004-01-21
US60/537503 2004-01-21
US63140704P 2004-11-30 2004-11-30
US60/631407 2004-11-30

Publications (3)

Publication Number Publication Date
JP2005206602A JP2005206602A (ja) 2005-08-04
JP2005206602A5 true JP2005206602A5 (OSRAM) 2008-03-06
JP4826995B2 JP4826995B2 (ja) 2011-11-30

Family

ID=34753090

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005013897A Expired - Lifetime JP4826995B2 (ja) 2004-01-21 2005-01-21 抗体の変質を防止する精製方法

Country Status (5)

Country Link
US (3) US8084032B2 (OSRAM)
EP (1) EP1568710B1 (OSRAM)
JP (1) JP4826995B2 (OSRAM)
CN (1) CN1680426B (OSRAM)
DE (1) DE602005018406D1 (OSRAM)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8084032B2 (en) 2004-01-21 2011-12-27 Ajinomoto Co., Inc. Purification method which prevents denaturation of an antibody
DE602006003108D1 (de) * 2005-03-03 2008-11-27 Ajinomoto Kk Methode zur Verbesserung der Ausbeute bei der Proteinreinigung mittels Gelfiltrationschromatographie und Arginin
CA2584230C (en) * 2005-05-06 2012-11-27 Gen-Probe Incorporated Methods of nucleic acid target capture
NZ573639A (en) * 2006-07-14 2012-03-30 Genentech Inc Refolding of recombinant proteins
AU2007292253A1 (en) * 2006-09-08 2008-03-13 Wyeth Arginine wash in protein purification using affinity chromatography
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
EP2500413A1 (en) 2006-09-13 2012-09-19 Abbott Laboratories Cell culture improvements
DK2089429T3 (en) 2006-10-19 2015-01-12 Janssen Biotech Inc PROCEDURE FOR MANUFACTURING NON-AGGREGATED ANTIBODY-FC DOMAINS
EP1958626B1 (en) * 2007-02-13 2014-07-23 Ajinomoto Co., Inc. Method for inactivating viruses by addition of slightly acidic arginine
CN102089319B (zh) * 2008-05-08 2013-11-13 味之素株式会社 蛋白质的重折叠方法
JP4542172B2 (ja) * 2008-05-19 2010-09-08 日本電波工業株式会社 感知装置及び感知方法
EP2321338A1 (en) * 2008-08-14 2011-05-18 Merck Sharp & Dohme Corp. Methods for purifying antibodies using protein a affinity chromatography
SG10201702951RA (en) 2008-10-20 2017-06-29 Abbvie Inc Viral inactivation during purification of antibodies
JP5808249B2 (ja) 2008-10-20 2015-11-10 アッヴィ・インコーポレイテッド プロテインaアフィニティークロマトグラフィーを用いる抗体の単離および精製
JP2011041475A (ja) * 2009-08-19 2011-03-03 Asahi Kasei Medical Co Ltd 抗体製造方法
PL3272764T3 (pl) * 2009-12-18 2024-06-10 Novartis Ag Sposób chromatografii powinowactwa
JP5567691B2 (ja) * 2010-01-22 2014-08-06 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Fc含有タンパク質を精製するためのクロマトグラフィー法
EP2538790B1 (en) 2010-02-26 2015-07-29 Ajinomoto Co., Inc. Virus-inactivating composition containing low-molecular weight compound and arginine
US20130096284A1 (en) * 2010-06-21 2013-04-18 Kyowa Hakko Kirin Co., Ltd. Method for purifying protein using amino acid
WO2012164046A1 (en) 2011-06-01 2012-12-06 Novartis Ag Wash solution and method for affinity chromatography
CN107365388B (zh) 2011-06-23 2021-05-14 味之素株式会社 多聚体蛋白的制备方法
US20150239956A1 (en) * 2012-06-27 2015-08-27 Asahi Kasei Medical Co., Ltd. High-affinity antibody and method for manufacturing the same
JP6411891B2 (ja) * 2012-10-03 2018-10-24 協和発酵キリン株式会社 培養液にアミノ酸を添加することによるポリペプチドの還元防止方法
PL3010537T3 (pl) 2013-06-17 2019-03-29 De Staat Der Nederlanden, Vert. Door De Minister Van Vws, Ministerie Van Volksgezondheid, Welzijn En Sport Sposoby zapobiegania agregacji komponentów wirusowych
JP6236948B2 (ja) * 2013-07-17 2017-11-29 東ソー株式会社 抗体精製用溶出液および当該溶出液を用いた抗体精製方法
CN105273041A (zh) * 2014-07-08 2016-01-27 上海中信国健药业股份有限公司 一种蛋白质亲和层析洗脱方法
TW201628649A (zh) 2014-10-09 2016-08-16 再生元醫藥公司 減少醫藥調配物中微可見顆粒之方法
EP3209332B1 (en) 2014-10-23 2021-05-26 Amgen Inc. Reducing viscosity of pharmaceutical formulations
US11566082B2 (en) 2014-11-17 2023-01-31 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
US20180273582A1 (en) * 2015-11-09 2018-09-27 University Of Notre Dame Small molecule affinity membrane purification systems and uses thereof
HRP20160086A2 (hr) 2016-01-27 2017-08-11 Sveučilište u Zagrebu Eluens za imunoafinitetnu kromatografiju virusa i proteina
US11186858B1 (en) 2016-03-15 2021-11-30 Fresenius Kabi Deutschland Gmbh Methods for increasing biosimilarity
JP7031934B2 (ja) 2016-05-11 2022-03-08 サイティバ・バイオプロセス・アールアンドディ・アクチボラグ 分離マトリックス
US10703774B2 (en) 2016-09-30 2020-07-07 Ge Healthcare Bioprocess R&D Ab Separation method
US11753438B2 (en) 2016-05-11 2023-09-12 Cytiva Bioprocess R&D Ab Method of cleaning and/or sanitizing a separation matrix
US10730908B2 (en) 2016-05-11 2020-08-04 Ge Healthcare Bioprocess R&D Ab Separation method
US10654887B2 (en) 2016-05-11 2020-05-19 Ge Healthcare Bio-Process R&D Ab Separation matrix
US10513537B2 (en) 2016-05-11 2019-12-24 Ge Healthcare Bioprocess R&D Ab Separation matrix
US10889615B2 (en) 2016-05-11 2021-01-12 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
JP7106187B2 (ja) 2016-05-11 2022-07-26 サイティバ・バイオプロセス・アールアンドディ・アクチボラグ 分離マトリックスを保存する方法
ES2994244T3 (en) 2016-07-25 2025-01-21 Cephalon Llc Affinity chromatography wash buffer
IL264631B2 (en) 2016-08-16 2024-05-01 Regeneron Pharma A method for quantifying individual antibodies from a mixture
US12448411B2 (en) 2016-09-30 2025-10-21 Cytiva Bioprocess R&D Ab Separation method
EP4071469B1 (en) 2016-10-25 2025-04-09 Regeneron Pharmaceuticals, Inc. Methods for chromatography data analysis
JP7377596B2 (ja) 2017-02-22 2023-11-10 アムジエン・インコーポレーテツド 低粘度、高濃度エボロクマブ製剤及びそれらの製造方法
WO2018185942A1 (ja) * 2017-04-07 2018-10-11 コニカミノルタ株式会社 タンパク質修飾蛍光体集積粒子の精製物を製造する方法、蛍光染色液の製造方法、タンパク質修飾蛍光体集積粒子の精製物、蛍光染色液およびタンパク質修飾蛍光体集積粒子精製用フィルター
WO2019060062A1 (en) 2017-09-19 2019-03-28 Regeneron Pharmaceuticals Inc. METHODS OF REDUCING PARTICLE FORMATION AND COMPOSITIONS FORMED THEREFROM
JP7158015B2 (ja) * 2017-11-09 2022-10-21 国立研究開発法人産業技術総合研究所 ポリペプチドの凝集化抑制方法
CN119881293A (zh) 2018-03-21 2025-04-25 沃特世科技公司 基于非抗体高亲和力的样品制备、吸附剂、装置和方法
TWI853823B (zh) 2018-07-02 2024-09-01 美商里珍納龍藥品有限公司 自混合物製備多肽之系統及方法
EP4007771A1 (en) 2019-08-02 2022-06-08 UCB Biopharma SRL Methods for purifying antibodies
CA3156648A1 (en) * 2019-10-04 2021-04-08 Merck Patent Gmbh ELUTION OF MONOCLONAL ANTIBODIES IN PROTEIN A AFFINITY CHROMATOGRAPHY
CN112898413A (zh) * 2021-04-07 2021-06-04 杭州奕安济世生物药业有限公司 采用亲和层析纯化减少抗体聚集的方法
CN113980092B (zh) * 2021-12-09 2024-05-14 上海药明生物技术有限公司 一种蛋白质亲和纯化方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1323567C (en) 1987-10-05 1993-10-26 Gene R. Nathans Method for purification of antibodies
JPH02273194A (ja) 1989-04-14 1990-11-07 Sumitomo Chem Co Ltd ヒトモノクローナル抗体の安定な精製法
AU5292693A (en) 1992-10-02 1994-04-26 General Hospital Corporation, The Affinity purification methods involving amino acid mimetics as elution reagents
US6171586B1 (en) * 1997-06-13 2001-01-09 Genentech, Inc. Antibody formulation
ES2321539T3 (es) 2001-06-05 2009-06-08 Genetics Institute, Llc Procedimientos relativos a la purificacion de proteinas altamente anionicas.
US8084032B2 (en) 2004-01-21 2011-12-27 Ajinomoto Co., Inc. Purification method which prevents denaturation of an antibody
DE602006003108D1 (de) 2005-03-03 2008-11-27 Ajinomoto Kk Methode zur Verbesserung der Ausbeute bei der Proteinreinigung mittels Gelfiltrationschromatographie und Arginin
EP1958626B1 (en) 2007-02-13 2014-07-23 Ajinomoto Co., Inc. Method for inactivating viruses by addition of slightly acidic arginine
CN102089319B (zh) 2008-05-08 2013-11-13 味之素株式会社 蛋白质的重折叠方法

Similar Documents

Publication Publication Date Title
JP2005206602A5 (OSRAM)
WO2006138553A3 (en) Methods of purifying fc region containing proteins
CA2482097A1 (en) Methods for isolating nucleic acids
DE602005014969D1 (de) Verfahren zur aufreinigung von albumin-konjugaten
NZ587511A (en) Purified lymphotoxin-beta-receptor immunoglobulin fusion proteins and methods of their purification
EP1568710A3 (en) Antibody purification method
WO2005047860A3 (en) Antibodies to alpha-synuclein
JP2012018171A5 (OSRAM)
WO2005050224A3 (en) Small molecule and peptide arrays and uses thereof
EP1477800A4 (en) Method and apparatus for analyzing amino acid, peptide, protein, saccharide or lipid
WO2009139601A3 (en) Method and affinity column for purifying proteins
ATE417056T1 (de) Verfahren zur proteinreinigung
WO2008003707A3 (en) Minimized small peptides with high affinity for factor viii and factor viii-like proteins
DE602004026500D1 (de) Verfahren zur Markierung phosphorylierten Peptiden, Komplexverbindunger, Verfahren zu deren Herstellung und Zwischenprodukte
EP1780537A4 (en) PROTEOMANALYSIS PROCESS FOR PHOSPHORYLATED PROTEIN
ATE335816T1 (de) Verfahren zum nachweis prokaryontischer dna
Acikara et al. Affinity chromatography and importance in drug discovery
WO2004008942A3 (en) Rapid process for purification and concentration of plasmin
ATE541037T1 (de) Verfahren zur trennung und reinigung von nukleinsäure
JP2009543099A5 (OSRAM)
JP2009518428A5 (OSRAM)
JP2009133739A5 (OSRAM)
RU2004103098A (ru) Способ прижизненного определения острой фазы стафилококкового среднего отита в эксперименте
Van Essche et al. VENTURE™ A-High Performance Analytical Column for the Purification of Antibodies
JP2005104906A (ja) 銅結合性ペプチド及びその使用